首页|抗菌药物相关迟发性皮疹的临床特点及其进展为重型皮疹的相关因素分析

抗菌药物相关迟发性皮疹的临床特点及其进展为重型皮疹的相关因素分析

扫码查看
目的:分析使用抗菌药物出现迟发性皮疹患者的临床特点及其进展为重型皮疹的相关因素,为抗菌药物迟发性皮疹患者的药学监护提供参考。方法:依据南京大学医学院附属鼓楼医院2020年5月至2023年5月使用抗菌药物出现皮疹的不良反应报告,收集患者基本特征、过敏史、不良反应发生情况及处理等信息,分析使用抗菌药物出现迟发性皮疹患者的临床资料,开展单因素分析及logistic回归分析迟发性皮疹患者进展为重型皮疹的相关因素。结果:该研究纳入使用抗菌药物出现迟发性皮疹的56例患者,其中头孢菌素类和糖肽类抗菌药物的致敏次数最多(各13例,各占比23。2%),皮疹发生时间多分布于抗菌药物使用后2~7d(36例,占比64。3%)。患者多使用抗组胺药治疗(24例,42。9%),28日全因死亡率为14。3%(8例)。56例患者被划分为发生严重皮肤不良反应(severe cutaneous adverse reactions,SCARs)组11例、未发生SCARs组45例。两组患者基础情况对比差异无统计学意义(P>0。05),单因素分析结果显示,两组间用药时间(Z=-2。281,P=0。023)、用药期间最高白细胞计数(Z=-2。186,P=0。029)、最高嗜酸性粒细胞计数(Z=-4。138,P<0。01)和最高单核细胞计数(Z=-2。757,P=0。006)存在显著性差异。多因素分析结果显示,用药期间最高嗜酸性粒细胞计数(OR=0。030,P=0。004)存在组间差异。ROC曲线分析结果显示,用药期间最高嗜酸性粒细胞计数的临界值为0。255×109 L-1,曲线下面积为0。905(0。826~0。984)。结论:导致患者发生抗菌药物相关迟发性皮疹的主要抗菌药物类别为头孢菌素类和糖肽类。用药期间嗜酸性粒细胞计数与SCARs密切相关,应在临床用药中加强监测。
Clinical characteristics of antimicrobial agent-associated delayed rashes and analysis of its related factors for progression to severe cutaneous adverse reactions
OBJECTIVE To explore the clinical characteristics of patients with delayed rashes on a therapy of antimicrobial agents and examine the related factors for progression to severe cutaneous adverse reactions(SCARs)to provide references for pharmacological monitoring.METHODS Based upon the adverse reaction reports of rashes related to antimicrobial agents from May 2020 to May 2023,basic profiles,allergy history and occurrence and adverse reactions were recorded.The relevant clinical were retrospectively reviewed and then univariate and logistic regression analyses performed.RESULTS A total of 56 patients on a therapy of antimicrobial agents developed delayed rashes.Cephalosporins and glycopeptides had the highest frequency of sensiti-zation(n=13,23.2%)and rashes occurred mostly at Days 2-7 after dosing(n=36,64.3%).Antihistamines were often pre-scribed(n=24,42.9%)and 28-day all-cause mortality after rashes was 14.3%(n=8).They were assigned into two groups of SCARs(n=11)and non-SCARs(n=45).No statistically significant inter-group difference existed in demographic profiles(P>0.05).Univariate analysis revealed that medication time(Z=-2.281,P=0.023),maximal leucocyte(Z=-2.186,P=0.029),maximal eosinophil(Eos)(Z=-4.138,P<0.01)and maximal monocyte(Mono)during medication(Z=-2.757,P=0.006)differed significantly between two groups.And multifactorial analysis indicated that maximal Eos during medication(OR=0.030,P=0.004)differed greatly between two groups.Receiver operating characteristic(ROC)curve analysis showed a critical value of 0.255×109L-1 for maximal Eos during medication with an area under the curve of 0.905(0.826-0.984).CONCLUSION Two major antimicrobial agents causing antimicrobial agent-related delayed rashes are cephalosporins and glycopeptides.And Eos dur-ing medication is a related factor for progression to SCARs and it should be monitored closely in clinical practices.

delayed rashessevere cutaneous adverse reactionsrelated factors

朱建柱、徐吟秋、梁培、张海霞

展开 >

南京中医药大学鼓楼临床医学院药学部,江苏南京 210008

南京大学医学院附属鼓楼医院,江苏南京 210008

南京临床药学中心,江苏南京 210008

迟发性皮疹 严重皮肤不良反应 相关因素

中国毒理学会临床毒理专项研究课题江苏省药学会-恒瑞医院药学基金科研项目

CST2019CT305H202106

2024

中国医院药学杂志
中国药学会

中国医院药学杂志

CSTPCD北大核心
影响因子:1.198
ISSN:1001-5213
年,卷(期):2024.44(13)